Investors

Discover Virbac's Statement on extra-financial performance

SALES 2023
1,247 M€
59%
Companion
animals
41%
Farm
animals

(in € million)

Financial public release
& News

2024 first quarter consolidated sales

2024/04/16 - Financial public releases

Building on the momentum of the second half of 2023, strong first-quarter revenue growth of +10.8% at constant exchange rates

Read more

Virbac acquired Sasaeah, a leading animal health player in Japan.

2024/04/02 - Financial public releases

Sasaeah.jpgOn April 1, we successfully completed the acquisition of Sasaeah. This strategic acquisition brings Virbac a leadership position in the farm animal vaccines market in Japan, notably in the cattle segment, and a large portfolio of pharmaceutical products for all the major species.

Read more

2023 Annual results

2024/03/19 - Financial public releases

●    Revenue up 4.9%, enabling market share gains despite difficulties in 2023

●    2023 operating profitability1 at an all-time high of 23.2% of revenue
     ○ Up 0.4 points compared to 2022 

●    Strong momentum expected in 2024
     ○  Expected revenue growth of 4% to 6% at constant exchange rates and scope
     ○  Operating profitability1 expected to rise by 0,5 point

 

Read more

Events
Tuesday July 16

2024 second quarter sales

From 2024/07/16

Read moreRead less

Tuesday july 16, 2024 after market close

2024 second quarter sales
(quiet period from July 2, 2024)

Friday September 13

2024 interim result

From 2024/09/13

Read moreRead less

Friday September 13, 2024 after market close

2024 interim result
(quiet period from August 16, 2024)

Monday September 16

SFAF meeting - 1st half 2024 financial & strategic information

From 2024/09/16

Read moreRead less

Monday September 16, 2024

SFAF meeting - 1st half 2024 financial & strategic information

Past Events
Friday June 21

Annual Ordinary General Meeting

From 2024/06/21

Read moreRead less

Friday June 21, 2024

Annual Ordinary General Meeting

Tuesday April 16

2024 first quarter sales

From 2024/04/16

Read moreRead less

Tuesday April 16, 2024 after market close

2024 first quarter sales
(quiet period from April 2, 2024)

Wednesday March 20

SFAF meeting - 2023 financial & strategic information

From 2024/03/20

Read moreRead less

Wednesday March 20, 2024
SFAF meeting - 2023 financial & strategic information
For more financial information

For more financial information

finances@virbac.com